医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ClearSight Announces Sale of Parent Company, Sharklet Technologies

2017年05月22日 PM11:00
このエントリーをはてなブックマークに追加


 

AURORA, Colo.

ClearSight LLC is pleased to announce the acquisition of its parent company Sharklet Technologies, Inc., by Peaceful Union, an equity medical device firm in Hangzhou, China. ClearSight LLC was co-founded by Drs. Kevin Cuevas and Shravanthi Reddy to develop the next generation intraocular lens (IOL) implant.

“We believe that the biomimetic approach used by Sharklet Technologies will not only produce the most advanced IOL, but will most likely enhance the performance of a wide range of ophthalmic products,” said Dr. Khalid “Kal” Mentak, CEO of ClearSight, LLC.

For more information see: www.clearsightiol.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20170522005319/en/

CONTACT

ClearSight
Shravanthi Reddy, COO
805-350-8216
sreddy@clearsightiol.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Samsung Bioepis’ Imraldi® (Adalimumab) Recommended for Approval by European Medicines Agency
  • BionextがBiosightを市場投入:医薬品研究に革命をもたらすオンラインプラットフォーム
  • Takeda Presents Data from Phase 1/2 Studies for NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma Patients and in the Maintenance Setting
  • 2017世界移动大会-上海参展商概况
  • 新研究比较Masimo下一代SedLine®患者状态指数(PSi)与原初Psi在麻醉期间的性能